|
1
|
Moreno-Layseca P, Icha J, Hamidi H and
Ivaska J: Integrin trafficking in cells and tissues. Nat Cell Biol.
21:122–132. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Calderwood DA, Campbell ID and Critchley
DR: Talins and kindlins: Partners in integrin-mediated adhesion.
Nat Rev Mol Cell Biol. 14:503–517. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Grigoryeva ES, Tashireva LA, Savelieva OE,
Zavyalova MV, Popova NO, Kuznetsov GA, Andryuhova ES and Perelmuter
VM: The association of integrins β3, β4, and αVβ5 on exosomes, CTCs
and tumor cells with localization of distant metastasis in breast
cancer patients. Int J Mol Sci. 24:29292023. View Article : Google Scholar
|
|
4
|
Liu F, Wu Q, Dong Z and Liu K: Integrins
in cancer: Emerging mechanisms and therapeutic opportunities.
Pharmacol Ther. 247:1084582023. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Mammadova-Bach E, Zigrino P, Brucker C,
Bourdon C, Freund M, De Arcangelis A, Abrams SI, Orend G, Gachet C
and Mangin PH: Platelet integrin α6β1 controls lung metastasis
through direct binding to cancer cell-derived ADAM9. JCI Insight.
1:e882452016. View Article : Google Scholar
|
|
6
|
Sun F, Wang J, Sun Q, Li F, Gao H, Xu L,
Zhang J, Sun X, Tian Y, Zhao Q, et al: Interleukin-8 promotes
integrin β3 upregulation and cell invasion through PI3K/Akt pathway
in hepatocellular carcinoma. J Exp Clin Cancer Res. 38:4492019.
View Article : Google Scholar
|
|
7
|
Reader CS, Vallath S, Steele CW, Haider S,
Brentnall A, Desai A, Moore KM, Jamieson NB, Chang D, Bailey P, et
al: The integrin αvβ6 drives pancreatic cancer through diverse
mechanisms and represents an effective target for therapy. J
Pathol. 249:332–342. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Gopal S, Veracini L, Grall D, Butori C,
Schaub S, Audebert S, Camoin L, Baudelet E, Radwanska A,
Beghelli-de la Forest Divonne S, et al: Fibronectin-guided
migration of carcinoma collectives. Nat Commun. 8:141052017.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Hamidi H and Ivaska J: Every step of the
way: Integrins in cancer progression and metastasis. Nat Rev
Cancer. 18:533–548. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Raab-Westphal S, Marshall JF and Goodman
SL: Integrins as therapeutic targets: Successes and cancers.
Cancers (Basel). 9:1102017. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Hamidi H, Pietilä M and Ivaska J: The
complexity of integrins in cancer and new scopes for therapeutic
targeting. Br J Cancer. 115:1017–1023. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Slack RJ, Macdonald SJF, Roper JA, Jenkins
RG and Hatley RJD: Emerging therapeutic opportunities for integrin
inhibitors. Nat Rev Drug Discov. 21:60–78. 2022. View Article : Google Scholar
|
|
13
|
Pegtel DM and Gould SJ: Exosomes. Annu Rev
Biochem. 88:487–514. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Kalluri R: The biology and function of
exosomes in cancer. J Clin Invest. 126:1208–1215. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Zhou Y, Zhang Y, Gong H, Luo S and Cui Y:
The role of exosomes and their applications in cancer. Int J Mol
Sci. 22:122042021. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Hoshino A, Costa-Silva B, Shen TL,
Rodrigues G, Hashimoto A, Tesic Mark M, Molina H, Kohsaka S, Di
Giannatale A, Ceder S, et al: Tumour exosome integrins determine
organotropic metastasis. Nature. 527:329–335. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Kalappurakkal JM, Anilkumar AA, Patra C,
van Zanten TS, Sheetz MP and Mayor S: Integrin mechano-chemical
signaling generates plasma membrane nanodomains that promote cell
spreading. Cell. 177:1738–1756.e23. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Lu H, Bowler N, Harshyne LA, Craig Hooper
D, Krishn SR, Kurtoglu S, Fedele C, Liu Q, Tang HY, Kossenkov AV,
et al: Exosomal αvβ6 integrin is required for monocyte M2
polarization in prostate cancer. Matrix Biol. 70:20–35. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Welsh JA, Goberdhan DCI, O'Driscoll L,
Buzas EI, Blenkiron C, Bussolati B, Cai H, Di Vizio D, Driedonks
TAP, Erdbrügger U, et al: Minimal information for studies of
extracellular vesicles (MISEV2023): From basic to advanced
approaches. J Extracell Vesicles. 13:e124042024. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Février B and Raposo G: Exosomes:
Endosomal-derived vesicles shipping extracellular messages. Curr
Opin Cell Biol. 16:415–421. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Valadi H, Ekström K, Bossios A, Sjöstrand
M, Lee JJ and Lötvall JO: Exosome-mediated transfer of mRNAs and
microRNAs is a novel mechanism of genetic exchange between cells.
Nat Cell Biol. 9:654–659. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Doyle L and Wang M: Overview of
extracellular vesicles, their origin, composition, purpose, and
methods for exosome isolation and analysis. Cells. 8:7272019.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Kalluri R and LeBleu VS: The biology,
function, and biomedical applications of exosomes. Science.
367:eaau69772020. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Mashouri L, Yousefi H, Aref AR, Ahadi AM,
Molaei F and Alahari SK: Exosomes: Composition, biogenesis, and
mechanisms in cancer metastasis and drug resistance. Mol Cancer.
18:752019. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Hurley JH: ESCRT complexes and the
biogenesis of multivesicular bodies. Curr Opin Cell Biol. 20:4–11.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Mathieu M, Martin-Jaular L, Lavieu G and
Théry C: Specificities of secretion and uptake of exosomes and
other extracellular vesicles for cell-to-cell communication. Nat
Cell Biol. 21:9–17. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Tricarico C, Clancy J and D'Souza-Schorey
C: Biology and biogenesis of shed microvesicles. Small GTPases.
8:220–232. 2017. View Article : Google Scholar :
|
|
28
|
Stuffers S, Sem Wegner C, Stenmark H and
Brech A: Multivesicular endosome biogenesis in the absence of
ESCRTs. Traffic. 10:925–937. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Theos AC, Truschel ST, Tenza D, Hurbain I,
Harper DC, Berson JF, Thomas PC, Raposo G and Marks MS: A novel
pathway for sorting to intralumenal vesicles of multivesicular
endosomes involved in organelle morphogenesis. Dev Cell.
10:343–354. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Yang K, Fu W, Deng M, Li X, Wu M and Wang
Y: The sphingolipids change in exosomes from cancer patients and
association between exosome release and sphingolipids level based
on a pseudotargeted lipidomics method. Anal Chim Acta.
1305:3425272024. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Guay C and Regazzi R: Exosomes as new
players in metabolic organ cross-talk. Diabetes Obes Metab.
19(Suppl 1): S137–S146. 2017. View Article : Google Scholar
|
|
32
|
Quek C and Hill AF: The role of
extracellular vesicles in neurodegenerative diseases. Biochem
Biophys Res Commun. 483:1178–1186. 2017. View Article : Google Scholar
|
|
33
|
Li Y, Chen ZK, Duan X, Zhang HJ, Xiao BL,
Wang KM and Chen G: Targeted inhibition of tumor-derived exosomes
as a novel therapeutic option for cancer. Exp Mol Med.
54:1379–1389. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Ciardiello C, Cavallini L, Spinelli C,
Yang J, Reis-Sobreiro M, de Candia P, Minciacchi VR and Di Vizio D:
Focus on extracellular vesicles: New frontiers of cell-to-cell
communication in cancer. Int J Mol Sci. 17:1752016. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Whiteside TL: Immune modulation of T-cell
and NK (natural killer) cell activities by TEXs (tumour-derived
exosomes). Biochem Soc Trans. 41:245–251. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Webber J, Steadman R, Mason MD, Tabi Z and
Clayton A: Cancer exosomes trigger fibroblast to myofibroblast
differentiation. Cancer Res. 70:9621–9630. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Rai A, Greening DW, Chen M, Xu R, Ji H and
Simpson RJ: Exosomes derived from human primary and metastatic
colorectal cancer cells contribute to functional heterogeneity of
activated fibroblasts by reprogramming their proteome. Proteomics.
19:e18001482019. View Article : Google Scholar
|
|
38
|
Cueni LN and Detmar M: The lymphatic
system in health and disease. Lymphat Res Biol. 6:109–122. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Yang E, Wang X, Gong Z, Yu M, Wu H and
Zhang D: Exosome-mediated metabolic reprogramming: The emerging
role in tumor microenvironment remodeling and its influence on
cancer progression. Signal Transduct Target Ther. 5:2422020.
View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Ludwig N and Whiteside TL: Potential roles
of tumor-derived exosomes in angiogenesis. Expert Opin Ther
Targets. 22:409–417. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Wu B, Liu DA, Guan L, Myint PK, Chin L,
Dang H, Xu Y, Ren J, Li T, Yu Z, et al: Stiff matrix induces
exosome secretion to promote tumour growth. Nat Cell Biol.
25:415–424. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Hynes RO: The emergence of integrins: A
personal and historical perspective. Matrix Biol. 23:333–340. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Campbell ID and Humphries MJ: Integrin
structure, activation, and interactions. Cold Spring Harb Perspect
Biol. 3:a0049942011. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Takada Y, Ye X and Simon S: The integrins.
Genome Biol. 8:2152007. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Van Der Flier A and Sonnenberg A: Function
and interactions of integrins. Cell Tissue Res. 305:285–298. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Zheng Y and Leftheris K: Insights into
protein-ligand interactions in integrin complexes: Advances in
structure determinations. J Med Chem. 63:5675–5696. 2020.
View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Humphries JD, Byron A and Humphries MJ:
Integrin ligands at a glance. J Cell Sci. 119:3901–3903. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Sun CC, Qu XJ and Gao ZH:
Arginine-glycine-aspartate-binding integrins as therapeutic and
diagnostic targets. Am J Ther. 23:e198–e207. 2016. View Article : Google Scholar
|
|
49
|
Mitroulis I, Alexaki VI, Kourtzelis I,
Ziogas A, Hajishengallis G and Chavakis T: Leukocyte integrins:
Role in leukocyte recruitment and as therapeutic targets in
inflammatory disease. Pharmacol Ther. 147:123–135. 2015. View Article : Google Scholar
|
|
50
|
Zeltz C and Gullberg D: The
integrin-collagen connection-a glue for tissue repair? J Cell Sci.
129:653–664. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Aumailley M: The laminin family. Cell
Adhes Migr. 7:48–55. 2013. View Article : Google Scholar
|
|
52
|
Pang X, He X, Qiu Z, Zhang H, Xie R, Liu
Z, Gu Y, Zhao N, Xiang Q and Cui Y: Targeting integrin pathways:
Mechanisms and advances in therapy. Signal Transduct Target Ther.
8:12023. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Anthis NJ and Campbell ID: The tail of
integrin activation. Trends Biochem Sci. 36:191–198. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Soe ZY, Park EJ and Shimaoka M: Integrin
regulation in immunological and cancerous cells and exosomes. Int J
Mol Sci. 22:21932021. View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Shattil SJ, Kim C and Ginsberg MH: The
final steps of integrin activation: The end game. Nat Rev Mol Cell
Biol. 11:288–300. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Ginsberg MH, Partridge A and Shattil SJ:
Integrin regulation. Curr Opin Cell Biol. 17:509–516. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
57
|
Ganguly KK, Pal S, Moulik S and Chatterjee
A: Integrins and metastasis. Cell Adhes Migr. 7:251–261. 2013.
View Article : Google Scholar
|
|
58
|
Zhang L, Qu J, Qi Y, Duan Y, Huang YW,
Zhou Z, Li P, Yao J, Huang B, Zhang S and Yu D: EZH2 engages TGFβ
signaling to promote breast cancer bone metastasis via integrin
β1-FAK activation. Nat Commun. 13:25432022. View Article : Google Scholar
|
|
59
|
Huang L, Wang F, Wang X, Su C, Wu S, Yang
C, Luo M, Zhang J and Fu L: M2-like macrophage-derived exosomes
facilitate metastasis in non-small-cell lung cancer by delivering
integrin αVβ3. MedComm (2020). 4:e1912022. View Article : Google Scholar
|
|
60
|
Hazelbag S, Kenter GG, Gorter A, Dreef EJ,
Koopman LA, Violette SM, Weinreb PH and Fleuren GJ: Overexpression
of the alpha v beta 6 integrin in cervical squamous cell carcinoma
is a prognostic factor for decreased survival. J Pathol.
212:316–324. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
61
|
Cantor DI, Cheruku HR, Nice EC and Baker
MS: Integrin αvβ6 sets the stage for colorectal cancer metastasis.
Cancer Metastasis Rev. 34:715–734. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
62
|
Li ZH, Zhou Y, Ding YX, Guo QL and Zhao L:
Roles of integrin in tumor development and the target inhibitors.
Chin J Nat Med. 17:241–251. 2019.PubMed/NCBI
|
|
63
|
Lawrence R, Watters M, Davies CR, Pantel K
and Lu YJ: Circulating tumour cells for early detection of
clinically relevant cancer. Nat Rev Clin Oncol. 20:487–500. 2023.
View Article : Google Scholar : PubMed/NCBI
|
|
64
|
Silva R, D'Amico G, Hodivala-Dilke KM and
Reynolds LE: Integrins: The keys to unlocking angiogenesis.
Arterioscler Thromb Vasc Biol. 28:1703–1713. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
65
|
Shimaoka M, Kawamoto E, Gaowa A, Okamoto T
and Park EJ: Connexins and integrins in exosomes. Cancers (Basel).
11:1062019. View Article : Google Scholar : PubMed/NCBI
|
|
66
|
Grigoryeva ES, Savelieva OE, Popova NO,
Cherdyntseva NV and Perelmuter VM: Do tumor exosome integrins alone
determine organotropic metastasis? Mol Biol Rep. 47:8145–8157.
2020. View Article : Google Scholar : PubMed/NCBI
|
|
67
|
Domenis R, Marino M, Cifù A, Scardino G,
Curcio F and Fabris M: Circulating exosomes express α4β7 integrin
and compete with CD4+ T cells for the binding to Vedolizumab. PLoS
One. 15:e02423422020. View Article : Google Scholar
|
|
68
|
Maman S and Witz IP: A history of
exploring cancer in context. Nat Rev Cancer. 18:359–376. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
69
|
Ma Z, Wang LZ, Cheng JT, Lam WST, Ma X,
Xiang X, Wong AL, Goh BC, Gong Q, Sethi G and Wang L: Targeting
hypoxia-inducible factor-1-mediated metastasis for cancer therapy.
Antioxid Redox Signal. 34:1484–1497. 2021. View Article : Google Scholar
|
|
70
|
Xu R, Rai A, Chen M, Suwakulsiri W,
Greening DW and Simpson RJ: Extracellular vesicles in
cancer-implications for future improvements in cancer care. Nat Rev
Clin Oncol. 15:617–638. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
71
|
Li K, Chen Y, Li A, Tan C and Liu X:
Exosomes play roles in sequential processes of tumor metastasis.
Int J Cancer. 144:1486–1495. 2019. View Article : Google Scholar
|
|
72
|
Roma-Rodrigues C, Mendes R, Baptista PV
and Fernandes AR: Targeting tumor microenvironment for cancer
therapy. Int J Mol Sci. 20:8402019. View Article : Google Scholar : PubMed/NCBI
|
|
73
|
Sahai E, Astsaturov I, Cukierman E,
DeNardo DG, Egeblad M, Evans RM, Fearon D, Greten FR, Hingorani SR,
Hunter T, et al: A framework for advancing our understanding of
cancer-associated fibroblasts. Nat Rev Cancer. 20:174–186. 2020.
View Article : Google Scholar : PubMed/NCBI
|
|
74
|
Sung JS, Kang CW, Kang S, Jang Y, Chae YC,
Kim BG and Cho NH: ITGB4-mediated metabolic reprogramming of
cancer-associated fibroblasts. Oncogene. 39:664–676. 2020.
View Article : Google Scholar
|
|
75
|
Fang T, Lv H, Lv G, Li T, Wang C, Han Q,
Yu L, Su B, Guo L, Huang S, et al: Tumor-derived exosomal
miR-1247-3p induces cancer-associated fibroblast activation to
foster lung metastasis of liver cancer. Nat Commun. 9:1912018.
View Article : Google Scholar : PubMed/NCBI
|
|
76
|
Grivennikov SI, Greten FR and Karin M:
Immunity, inflammation, and cancer. Cell. 140:883–899. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
77
|
Xiao Y and Yu D: Tumor microenvironment as
a therapeutic target in cancer. Pharmacol Ther. 221:1077532021.
View Article : Google Scholar :
|
|
78
|
Pankov R, Cukierman E, Katz BZ, Matsumoto
K, Lin DC, Lin S, Hahn C and Yamada KM: Integrin dynamics and
matrix assembly: Tensin-dependent translocation of alpha(5)beta(1)
integrins promotes early fibronectin fibrillogenesis. J Cell Biol.
148:1075–1090. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
79
|
Bachmann M, Kukkurainen S, Hytönen VP and
Wehrle-Haller B: Cell adhesion by integrins. Physiol Rev.
99:1655–1699. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
80
|
Yazlovitskaya EM, Viquez OM, Tu T, De
Arcangelis A, Georges-Labouesse E, Sonnenberg A, Pozzi A and Zent
R: The laminin binding α3 and α6 integrins cooperate to promote
epithelial cell adhesion and growth. Matrix Biol. 77:101–116. 2019.
View Article : Google Scholar
|
|
81
|
Somanath PR, Malinin NL and Byzova TV:
Cooperation between integrin alphavbeta3 and VEGFR2 in
angiogenesis. Angiogenesis. 12:177–185. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
82
|
Kanchanawong P and Calderwood DA:
Organization, dynamics and mechanoregulation of integrin-mediated
cell-ECM adhesions. Nat Rev Mol Cell Biol. 24:142–161. 2023.
View Article : Google Scholar
|
|
83
|
Nieto MA, Huang RYJ, Jackson RA and Thiery
JP: EMT: 2016. Cell. 166:21–45. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
84
|
Liao TT and Yang MH: Revisiting
epithelial-mesenchymal transition in cancer metastasis: The
connection between epithelial plasticity and stemness. Mol Oncol.
11:792–804. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
85
|
Liao TT and Yang MH: Hybrid
epithelial/mesenchymal state in cancer metastasis: Clinical
significance and regulatory mechanisms. Cells. 9:6232020.
View Article : Google Scholar : PubMed/NCBI
|
|
86
|
Lu W and Kang Y: Epithelial-mesenchymal
plasticity in cancer progression and metastasis. Dev Cell.
49:361–374. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
87
|
Grünert S, Jechlinger M and Beug H:
Diverse cellular and molecular mechanisms contribute to epithelial
plasticity and metastasis. Nat Rev Mol Cell Biol. 4:657–665. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
88
|
Lambert AW, Pattabiraman DR and Weinberg
RA: Emerging biological principles of metastasis. Cell.
168:670–691. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
89
|
Tanabe S, Quader S, Cabral H and Ono R:
Interplay of EMT and CSC in cancer and the potential therapeutic
strategies. Front Pharmacol. 11:9042020. View Article : Google Scholar : PubMed/NCBI
|
|
90
|
Syn N, Wang L, Sethi G, Thiery JP and Goh
BC: Exosome-mediated metastasis: From epithelial-mesenchymal
transition to escape from immunosurveillance. Trends Pharmacol Sci.
37:606–617. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
91
|
Yeung KT and Yang J:
Epithelial-mesenchymal transition in tumor metastasis. Mol Oncol.
11:28–39. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
92
|
Mamuya FA and Duncan MK: aV integrins and
TGF-β-induced EMT: A circle of regulation. J Cell Mol Med.
16:445–455. 2012. View Article : Google Scholar :
|
|
93
|
Caramel J, Papadogeorgakis E, Hill L,
Browne GJ, Richard G, Wierinckx A, Saldanha G, Osborne J,
Hutchinson P, Tse G, et al: A switch in the expression of embryonic
EMT-inducers drives the development of malignant melanoma. Cancer
Cell. 24:466–480. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
94
|
Ji Q, Zhou L, Sui H, Yang L, Wu X, Song Q,
Jia R, Li R, Sun J, Wang Z, et al: Primary tumors release
ITGBL1-rich extracellular vesicles to promote distal metastatic
tumor growth through fibroblast-niche formation. Nat Commun.
11:12112020. View Article : Google Scholar : PubMed/NCBI
|
|
95
|
Wen S, Hou Y, Fu L, Xi L, Yang D, Zhao M,
Qin Y, Sun K, Teng Y and Liu M: Cancer-associated fibroblast
(CAF)-derived IL32 promotes breast cancer cell invasion and
metastasis via integrin β3-p38 MAPK signalling. Cancer Lett.
442:320–332. 2019. View Article : Google Scholar
|
|
96
|
Huang Y, Hong W and Wei X: The molecular
mechanisms and therapeutic strategies of EMT in tumor progression
and metastasis. J Hematol Oncol. 15:1292022. View Article : Google Scholar : PubMed/NCBI
|
|
97
|
Hao Q, Wu Y, Wu Y, Wang P and Vadgama JV:
Tumor-derived exosomes in tumor-induced immune suppression. Int J
Mol Sci. 23:14612022. View Article : Google Scholar : PubMed/NCBI
|
|
98
|
Zhao L, Ma X and Yu J: Exosomes and
organ-specific metastasis. Mol Ther Methods Clin Dev. 22:133–147.
2021. View Article : Google Scholar : PubMed/NCBI
|
|
99
|
Chen Y, Yang S, Tavormina J, Tampe D,
Zeisberg M, Wang H, Mahadevan KK, Wu CJ, Sugimoto H, Chang CC, et
al: Oncogenic collagen I homotrimers from cancer cells bind to α3β1
integrin and impact tumor microbiome and immunity to promote
pancreatic cancer. Cancer Cell. 40:818–834.e9. 2022. View Article : Google Scholar
|
|
100
|
Genduso S, Freytag V, Schetler D, Kirchner
L, Schiecke A, Maar H, Wicklein D, Gebauer F, Bröker K, Stürken C,
et al: Tumor cell integrin β4 and tumor stroma E-/P-selectin
cooperatively regulate tumor growth in vivo. J Hematol Oncol.
16:232023. View Article : Google Scholar
|
|
101
|
Zhang Y, Xie R, Zhang H, Zheng Y, Lin C,
Yang L, Huang M, Li M, Song F, Lu L, et al: Integrin β7 inhibits
colorectal cancer pathogenesis via maintaining antitumor immunity.
Cancer Immunol Res. 9:967–980. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
102
|
Ruan S, Lin M, Zhu Y, Lum LG, Thakur A,
Jin R, Shao W, Zhang Y, Hu Y, Huang S, et al: Integrin β4-targeted
cancer immunotherapies inhibit tumor growth and decrease
metastasis. Cancer Res. 80:771–783. 2020. View Article : Google Scholar
|
|
103
|
Vannini A, Leoni V, Barboni C, Sanapo M,
Zaghini A, Malatesta P, Campadelli-Fiume G and Gianni T:
αvβ3-integrin regulates PD-L1 expression and is involved in cancer
immune evasion. Proc Natl Acad Sci USA. 116:20141–20150. 2019.
View Article : Google Scholar
|
|
104
|
Ren D, Zhao J, Sun Y, Li D, Meng Z, Wang
B, Fan P, Liu Z, Jin X and Wu H: Overexpressed ITGA2 promotes
malignant tumor aggression by up-regulating PD-L1 expression
through the activation of the STAT3 signaling pathway. J Exp Clin
Cancer Res. 38:4852019. View Article : Google Scholar : PubMed/NCBI
|
|
105
|
Lainé A, Labiad O, Hernandez-Vargas H,
This S, Sanlaville A, Léon S, Dalle S, Sheppard D, Travis MA,
Paidassi H and Marie JC: Regulatory T cells promote cancer
immune-escape through integrin αvβ8-mediated TGF-β activation. Nat
Commun. 12:62282021. View Article : Google Scholar
|
|
106
|
Takasaka N, Seed RI, Cormier A, Bondesson
AJ, Lou J, Elattma A, Ito S, Yanagisawa H, Hashimoto M, Ma R, et
al: Integrin αvβ8-expressing tumor cells evade host immunity by
regulating TGF-β activation in immune cells. JCI Insight.
3:e1225912018. View Article : Google Scholar
|
|
107
|
Balkwill F and Mantovani A: Inflammation
and cancer: Back to virchow? Lancet. 357:539–545. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
108
|
Myint PK, Park EJ, Gaowa A, Kawamoto E and
Shimaoka M: Targeted remodeling of breast cancer and immune cell
homing niches by exosomal integrins. Diagn Pathol. 15:382020.
View Article : Google Scholar : PubMed/NCBI
|
|
109
|
Lukanidin E and Sleeman JP: Building the
niche: The role of the S100 proteins in metastatic growth. Semin
Cancer Biol. 22:216–225. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
110
|
Nagaraj S, Gupta K, Pisarev V, Kinarsky L,
Sherman S, Kang L, Herber DL, Schneck J and Gabrilovich DI: Altered
recognition of antigen is a mechanism of CD8+ T cell
tolerance in cancer. Nat Med. 13:828–835. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
111
|
Ichikawa M, Williams R, Wang L, Vogl T and
Srikrishna G: S100A8/A9 activate key genes and pathways in colon
tumor progression. Mol Cancer Res. 9:133–148. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
112
|
Nishida N, Yano H, Nishida T, Kamura T and
Kojiro M: Angiogenesis in cancer. Vasc Health Risk Manag.
2:213–219. 2006. View Article : Google Scholar
|
|
113
|
Sharghi-Namini S, Tan E, Ong LLS, Ge R and
Asada HH: Dll4-containing exosomes induce capillary sprout
retraction in a 3D microenvironment. Sci Rep. 4:40312014.
View Article : Google Scholar : PubMed/NCBI
|
|
114
|
Nazarenko I, Rana S, Baumann A, McAlear J,
Hellwig A, Trendelenburg M, Lochnit G, Preissner KT and Zöller M:
Cell surface tetraspanin Tspan8 contributes to molecular pathways
of exosome-induced endothelial cell activation. Cancer Res.
70:1668–1678. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
115
|
Krishn SR, Singh A, Bowler N, Duffy AN,
Friedman A, Fedele C, Kurtoglu S, Tripathi SK, Wang K, Hawkins A,
et al: Prostate cancer sheds the αvβ3 integrin in vivo through
exosomes. Matrix Biol. 77:41–57. 2019. View Article : Google Scholar
|
|
116
|
Harney AS, Arwert EN, Entenberg D, Wang Y,
Guo P, Qian BZ, Oktay MH, Pollard JW, Jones JG and Condeelis JS:
Real-time imaging reveals local, transient vascular permeability
and tumor cell intravasation stimulated by Tie2Hi
macrophage-derived VEGFA. Cancer Discov. 5:932–943. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
117
|
Sixt M, Bauer M, Lämmermann T and Fässler
R: Beta1 integrins: Zip codes and signaling relay for blood cells.
Curr Opin Cell Biol. 18:482–490. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
118
|
Sun L, Guo S, Xie Y and Yao Y: The
characteristics and the multiple functions of integrin β1 in human
cancers. J Transl Med. 21:7872023. View Article : Google Scholar
|
|
119
|
Jin H, Su J, Garmy-Susini B, Kleeman J and
Varner J: Integrin alpha4beta1 promotes monocyte trafficking and
angiogenesis in tumors. Cancer Res. 66:2146–2152. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
120
|
Weis SM: Evaluating integrin function in
models of angiogenesis and vascular permeability. Methods Enzymol.
426:505–528. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
121
|
Sobierajska K, Ciszewski WM,
Sacewicz-Hofman I and Niewiarowska J: Endothelial cells in the
tumor microenvironment. Adv Exp Med Biol. 1234:71–86. 2020.
View Article : Google Scholar : PubMed/NCBI
|
|
122
|
Labelle M and Hynes RO: The initial hours
of metastasis: The importance of cooperative host-tumor cell
interactions during hematogenous dissemination. Cancer Discov.
2:1091–1099. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
123
|
Peinado H, Lavotshkin S and Lyden D: The
secreted factors responsible for pre-metastatic niche formation:
Old sayings and new thoughts. Semin Cancer Biol. 21:139–146. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
124
|
Coleman RE, Croucher PI, Padhani AR,
Clézardin P, Chow E, Fallon M, Guise T, Colangeli S, Capanna R and
Costa L: Bone metastases. Nat Rev Dis Primer. 6:832020. View Article : Google Scholar
|
|
125
|
Nguyen DX, Bos PD and Massagué J:
Metastasis: From dissemination to organ-specific colonization. Nat
Rev Cancer. 9:274–284. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
126
|
Peinado H, Zhang H, Matei IR, Costa-Silva
B, Hoshino A, Rodrigues G, Psaila B, Kaplan RN, Bromberg JF, Kang
Y, et al: Pre-metastatic niches: Organ-specific homes for
metastases. Nat Rev Cancer. 17:302–317. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
127
|
Sceneay J, Smyth MJ and Möller A: The
pre-metastatic niche: Finding common ground. Cancer Metastasis Rev.
32:449–464. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
128
|
Kaplan RN, Riba RD, Zacharoulis S, Bramley
AH, Vincent L, Costa C, MacDonald DD, Jin DK, Shido K, Kerns SA, et
al: VEGFR1-positive haematopoietic bone marrow progenitors initiate
the pre-metastatic niche. Nature. 438:820–827. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
129
|
Liu Y and Cao X: Characteristics and
significance of the pre-metastatic niche. Cancer Cell. 30:668–681.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
130
|
Peinado H, Alečković M, Lavotshkin S,
Matei I, Costa-Silva B, Moreno-Bueno G, Hergueta-Redondo M,
Williams C, García-Santos G, Ghajar C, et al: Melanoma exosomes
educate bone marrow progenitor cells toward a pro-metastatic
phenotype through MET. Nat Med. 18:883–891. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
131
|
Costa-Silva B, Aiello NM, Ocean AJ, Singh
S, Zhang H, Thakur BK, Becker A, Hoshino A, Mark MT, Molina H, et
al: Pancreatic cancer exosomes initiate pre-metastatic niche
formation in the liver. Nat Cell Biol. 17:816–826. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
132
|
Desgrosellier JS and Cheresh DA: Integrins
in cancer: Biological implications and therapeutic opportunities.
Nat Rev Cancer. 10:9–22. 2010. View Article : Google Scholar
|
|
133
|
Fedele C, Singh A, Zerlanko BJ, Iozzo RV
and Languino LR: The αvβ6 integrin is transferred intercellularly
via exosomes. J Biol Chem. 290:4545–4551. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
134
|
Zhang X: Interactions between cancer cells
and bone microenvironment promote bone metastasis in prostate
cancer. Cancer Commun (Lond). 39:762019. View Article : Google Scholar : PubMed/NCBI
|
|
135
|
Geng X, Chang B and Shan J: Role and
correlation of exosomes and integrins in bone metastasis of
prostate cancer. Andrologia. 54:e145502022. View Article : Google Scholar : PubMed/NCBI
|
|
136
|
Tang L, Xu M, Zhang L, Qu L and Liu X:
Role of αVβ3 in prostate cancer: Metastasis initiator and important
therapeutic target. Onco Targets Ther. 13:7411–7422. 2020.
View Article : Google Scholar :
|
|
137
|
Chen GY, Cheng JCH, Chen YF, Yang JCH and
Hsu FM: Circulating exosomal integrin β3 is associated with
intracranial failure and survival in lung cancer patients receiving
cranial irradiation for brain metastases: A prospective
observational study. Cancers (Basel). 13:3802021. View Article : Google Scholar
|
|
138
|
Bijnsdorp IV, Geldof AA, Lavaei M, Piersma
SR, Van Moorselaar RJA and Jimenez CR: Exosomal ITGA3 interferes
with non-cancerous prostate cell functions and is increased in
urine exosomes of metastatic prostate cancer patients. J Extracell
Vesicles. 2: View Article : Google Scholar : 2013.PubMed/NCBI
|
|
139
|
Dallavalle S, Dobričić V, Lazzarato L,
Gazzano E, Machuqueiro M, Pajeva I, Tsakovska I, Zidar N and
Fruttero R: Improvement of conventional anti-cancer drugs as new
tools against multidrug resistant tumors. Drug Resist Updat.
50:1006822020. View Article : Google Scholar : PubMed/NCBI
|
|
140
|
Sousa D, Lima RT and Vasconcelos MH:
Intercellular transfer of cancer drug resistance traits by
extracellular vesicles. Trends Mol Med. 21:595–608. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
141
|
Lv MM, Zhu XY, Chen WX, Zhong SL, Hu Q, Ma
TF, Zhang J, Chen L, Tang JH and Zhao JH: Exosomes mediate drug
resistance transfer in MCF-7 breast cancer cells and a probable
mechanism is delivery of P-glycoprotein. Tumor Biol.
35:10773–10779. 2014. View Article : Google Scholar
|
|
142
|
Wang B, Zhang Y, Ye M, Wu J, Ma L and Chen
H: Cisplatin-resistant MDA-MB-231 cell-derived exosomes increase
the resistance of recipient cells in an exosomal
miR-423-5p-dependent manner. Curr Drug Metab. 20:804–814. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
143
|
Dong X, Bai X, Ni J, Zhang H, Duan W,
Graham P and Li Y: Exosomes and breast cancer drug resistance. Cell
Death Dis. 11:9872020. View Article : Google Scholar : PubMed/NCBI
|
|
144
|
Martinez VG, O'Neill S, Salimu J, Breslin
S, Clayton A, Crown J and O'Driscoll L: Resistance to HER2-targeted
anti-cancer drugs is associated with immune evasion in cancer cells
and their derived extracellular vesicles. Oncoimmunology.
6:e13625302017. View Article : Google Scholar : PubMed/NCBI
|
|
145
|
Safaei R, Larson BJ, Cheng TC, Gibson MA,
Otani S, Naerdemann W and Howell SB: Abnormal lysosomal trafficking
and enhanced exosomal export of cisplatin in drug-resistant human
ovarian carcinoma cells. Mol Cancer Ther. 4:1595–1604. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
146
|
Goler-Baron V and Assaraf YG: Structure
and function of ABCG2-rich extracellular vesicles mediating
multidrug resistance. PLoS One. 6:e160072011. View Article : Google Scholar : PubMed/NCBI
|
|
147
|
Mollazadeh S, Sahebkar A, Hadizadeh F,
Behravan J and Arabzadeh S: Structural and functional aspects of
P-glycoprotein and its inhibitors. Life Sci. 214:118–123. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
148
|
Zhang YH, Gao ZF, Dong GH, Li X, Wu Y, Li
G, Wang AL, Li HL and Yin DL: Suppression of αvβ6 downregulates
P-glycoprotein and sensitizes multidrug-resistant breast cancer
cells to anticancer drugs. Neoplasma. 67:379–388. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
149
|
Lopes-Rodrigues V, Seca H, Sousa D, Sousa
E, Lima RT and Vasconcelos MH: The network of P-glycoprotein and
microRNAs interactions. Int J Cancer. 135:253–263. 2014. View Article : Google Scholar
|
|
150
|
Damiano JS, Cress AE, Hazlehurst LA, Shtil
AA and Dalton WS: Cell adhesion mediated drug resistance (CAM-DR):
Role of integrins and resistance to apoptosis in human myeloma cell
lines. Blood. 93:1658–1667. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
151
|
Seguin L, Desgrosellier JS, Weis SM and
Cheresh DA: Integrins and cancer: Regulators of cancer stemness,
metastasis, and drug resistance. Trends Cell Biol. 25:234–240.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
152
|
Cooper J and Giancotti FG: Integrin
signaling in cancer: Mechanotransduction, stemness, epithelial
plasticity, and therapeutic resistance. Cancer Cell. 35:347–367.
2019. View Article : Google Scholar : PubMed/NCBI
|
|
153
|
Kanda R, Kawahara A, Watari K, Murakami Y,
Sonoda K, Maeda M, Fujita H, Kage M, Uramoto H, Costa C, et al:
Erlotinib resistance in lung cancer cells mediated by integrin
β1/Src/Akt-driven bypass signaling. Cancer Res. 73:6243–6253. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
154
|
Janouskova H, Maglott A, Leger DY, Bossert
C, Noulet F, Guerin E, Guenot D, Pinel S, Chastagner P, Plenat F,
et al: Integrin α5β1 plays a critical role in resistance to
temozolomide by interfering with the p53 pathway in high-grade
glioma. Cancer Res. 72:3463–3470. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
155
|
Luo J, Yao JF, Deng XF, Zheng XD, Jia M,
Wang YQ, Huang Y and Zhu JH: 14, 15-EET induces breast cancer cell
EMT and cisplatin resistance by up-regulating integrin αvβ3 and
activating FAK/PI3K/AKT signaling. J Exp Clin Cancer Res.
37:232018. View Article : Google Scholar
|
|
156
|
Khademi R, Malekzadeh H, Bahrami S, Saki
N, Khademi R and Villa-Diaz LG: Regulation and functions of
α6-integrin (CD49f) in cancer biology. Cancers (Basel).
15:34662023. View Article : Google Scholar
|
|
157
|
Kawakami K, Fujita Y, Kato T, Mizutani K,
Kameyama K, Tsumoto H, Miura Y, Deguchi T and Ito M: Integrin β4
and vinculin contained in exosomes are potential markers for
progression of prostate cancer associated with taxane-resistance.
Int J Oncol. 47:384–390. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
158
|
Tenchov R, Sasso JM, Wang X, Liaw WS, Chen
CA and Zhou QA: Exosomes-nature's lipid nanoparticles, a rising
star in drug delivery and diagnostics. ACS Nano. 16:17802–17846.
2022. View Article : Google Scholar : PubMed/NCBI
|
|
159
|
Kim MS, Haney MJ, Zhao Y, Mahajan V,
Deygen I, Klyachko NL, Inskoe E, Piroyan A, Sokolsky M, Okolie O,
et al: Development of exosome-encapsulated paclitaxel to overcome
MDR in cancer cells. Nanomedicine. 12:655–664. 2016. View Article : Google Scholar
|
|
160
|
Kobayashi M, Sawada K, Miyamoto M, Shimizu
A, Yamamoto M, Kinose Y, Nakamura K, Kawano M, Kodama M, Hashimoto
K and Kimura T: Exploring the potential of engineered exosomes as
delivery systems for tumor-suppressor microRNA replacement therapy
in ovarian cancer. Biochem Biophys Res Commun. 527:153–161. 2020.
View Article : Google Scholar : PubMed/NCBI
|
|
161
|
Cho E, Nam GH, Hong Y, Kim YK, Kim DH,
Yang Y and Kim IS: Comparison of exosomes and ferritin protein
nanocages for the delivery of membrane protein therapeutics. J
Controlled Release. 279:326–335. 2018. View Article : Google Scholar
|
|
162
|
Alvarez-Erviti L, Seow Y, Yin H, Betts C,
Lakhal S and Wood MJA: Delivery of siRNA to the mouse brain by
systemic injection of targeted exosomes. Nat Biotechnol.
29:341–345. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
163
|
Gaurav I, Thakur A, Iyaswamy A, Wang X,
Chen X and Yang Z: Factors affecting extracellular vesicles based
drug delivery systems. Molecules. 26:15442021. View Article : Google Scholar : PubMed/NCBI
|
|
164
|
Li MY, Liu LZ and Dong M: Progress on
pivotal role and application of exosome in lung cancer
carcinogenesis, diagnosis, therapy and prognosis. Mol Cancer.
20:222021. View Article : Google Scholar : PubMed/NCBI
|
|
165
|
Zhao L, Wang H, Fu J, Wu X, Liang XY, Liu
XY, Wu X, Cao LL, Xu ZY and Dong M: Microfluidic-based exosome
isolation and highly sensitive aptamer exosome membrane protein
detection for lung cancer diagnosis. Biosens Bioelectron.
214:1144872022. View Article : Google Scholar : PubMed/NCBI
|
|
166
|
Zhang L and Yu D: Exosomes in cancer
development, metastasis, and immunity. Biochim Biophys Acta Rev
Cancer. 1871:455–468. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
167
|
Yang H, Xu Z, Peng Y, Wang J and Xiang Y:
Integrin β4 as a potential diagnostic and therapeutic tumor marker.
Biomolecules. 11:11972021. View Article : Google Scholar
|
|
168
|
Valdembri D and Serini G: The roles of
integrins in cancer. Fac Rev. 10:452021. View Article : Google Scholar : PubMed/NCBI
|
|
169
|
Hurwitz SN and Meckes DG Jr: Extracellular
vesicle integrins distinguish unique cancers. Proteomes. 7:142019.
View Article : Google Scholar : PubMed/NCBI
|
|
170
|
Zhang Z, Wang Z, Liu T, Tang J, Liu Y, Gou
T, Chen K, Wang L, Zhang J, Yang Y and Zhang H: Exploring the role
of ITGB6: Fibrosis, cancer, and other diseases. Apoptosis.
29:570–585. 2024. View Article : Google Scholar
|
|
171
|
Bandyopadhyay A and Raghavan S: Defining
the role of integrin αvβ6 in cancer. Curr Drug Targets. 10:645–652.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
172
|
Hausner SH, DiCara D, Marik J, Marshall JF
and Sutcliffe JL: Use of a peptide derived from foot-and-mouth
disease virus for the noninvasive imaging of human cancer:
Generation and evaluation of 4-[18F]fluorobenzoyl A20FMDV2 for in
vivo imaging of integrin alphavbeta6 expression with positron
emission tomography. Cancer Res. 67:7833–7840. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
173
|
Su L, Chen Y, Huang C, Wu S, Wang X, Zhao
X, Xu Q, Sun R, Kong X, Jiang X, et al: Targeting Src reactivates
pyroptosis to reverse chemoresistance in lung and pancreatic cancer
models. Sci Transl Med. 15:eabl78952023. View Article : Google Scholar : PubMed/NCBI
|
|
174
|
Chen JR, Zhao JT and Xie ZZ:
Integrin-mediated cancer progression as a specific target in
clinical therapy. Biomed Pharmacother. 155:1137452022. View Article : Google Scholar : PubMed/NCBI
|
|
175
|
Zhang L, Gülses A, Purcz N, Weimer J,
Wiltfang J and Açil Y: A comparative assessment of the effects of
integrin inhibitor cilengitide on primary culture of head and neck
squamous cell carcinoma (HNSCC) and HNSCC cell lines. Clin Transl
Oncol. 21:1052–1060. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
176
|
Yu Q, Xiao W, Sun S, Sohrabi A, Liang J
and Seidlits SK: Extracellular matrix proteins confer cell
adhesion-mediated drug resistance through integrin αv in
glioblastoma cells. Front Cell Dev Biol. 9:6165802021. View Article : Google Scholar
|
|
177
|
Ignatiadis M, Sledge GW and Jeffrey SS:
Liquid biopsy enters the clinic-implementation issues and future
challenges. Nat Rev Clin Oncol. 18:297–312. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
178
|
Yu W, Hurley J, Roberts D, Chakrabortty
SK, Enderle D, Noerholm M, Breakefield XO and Skog JK:
Exosome-based liquid biopsies in cancer: Opportunities and
challenges. Ann Oncol. 32:466–477. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
179
|
Bergonzini C, Kroese K, Zweemer AJM and
Danen EHJ: Targeting integrins for cancer therapy-disappointments
and opportunities. Front Cell Dev Biol. 10:8638502022. View Article : Google Scholar
|
|
180
|
Cox D: How not to discover a
drug-integrins. Expert Opin Drug Discov. 16:197–211. 2021.
View Article : Google Scholar
|
|
181
|
Tam SH, Sassoli PM, Jordan RE and Nakada
MT: Abciximab (ReoPro, chimeric 7E3 Fab) demonstrates equivalent
affinity and functional blockade of glycoprotein IIb/IIIa and
alpha(v)beta3 integrins. Circulation. 98:1085–1091. 1998.
View Article : Google Scholar : PubMed/NCBI
|
|
182
|
Corcoran C, Rani S, O'Brien K, O'Neill A,
Prencipe M, Sheikh R, Webb G, McDermott R, Watson W, Crown J and
O'Driscoll L: Docetaxel-resistance in prostate cancer: Evaluating
associated phenotypic changes and potential for resistance transfer
via exosomes. PLoS One. 7:e509992012. View Article : Google Scholar : PubMed/NCBI
|
|
183
|
Xiao X, Yu S, Li S, Wu J, Ma R, Cao H, Zhu
Y and Feng J: Exosomes: Decreased sensitivity of lung cancer A549
cells to cisplatin. PLoS One. 9:e895342014. View Article : Google Scholar : PubMed/NCBI
|
|
184
|
Hazlehurst LA, Argilagos RF and Dalton WS:
Beta1 integrin mediated adhesion increases Bim protein degradation
and contributes to drug resistance in leukaemia cells. Br J
Haematol. 136:269–275. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
185
|
Wei H, Chen J, Wang S, Fu F, Zhu X, Wu C,
Liu Z, Zhong G and Lin J: A nanodrug consisting of doxorubicin and
exosome derived from mesenchymal stem cells for osteosarcoma
treatment in vitro. Int J Nanomedicine. 14:8603–8610. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
186
|
Tian Y, Li S, Song J, Ji T, Zhu M,
Anderson GJ, Wei J and Nie G: A doxorubicin delivery platform using
engineered natural membrane vesicle exosomes for targeted tumor
therapy. Biomaterials. 35:2383–2390. 2014. View Article : Google Scholar
|
|
187
|
Chen K and Chen X: Integrin targeted
delivery of chemotherapeutics. Theranostics. 1:189–200. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
188
|
Albelda SM, Mette SA, Elder DE, Stewart R,
Damjanovich L, Herlyn M and Buck CA: Integrin distribution in
malignant melanoma: Association of the beta 3 subunit with tumor
progression. Cancer Res. 50:6757–6764. 1990.PubMed/NCBI
|
|
189
|
Choi H, Choi Y, Yim HY, Mirzaaghasi A, Yoo
JK and Choi C: Biodistribution of exosomes and engineering
strategies for targeted delivery of therapeutic exosomes. Tissue
Eng Regen Med. 18:499–511. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
190
|
Gingras MC, Roussel E, Bruner JM, Branch
CD and Moser RP: Comparison of cell adhesion molecule expression
between glioblastoma multiforme and autologous normal brain tissue.
J Neuroimmunol. 57:143–153. 1995. View Article : Google Scholar : PubMed/NCBI
|
